Authors:
BARKSDALE CM
NORDBLOM GD
DUDECK RC
WELTY DF
JORDAN S
BIGGE CF
YI CS
Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID, Journal of clinical ligand assay, 21(3), 1998, pp. 324-330
Authors:
ROTHSTEIN JD
DYKESHOBERG M
PARDO CA
BRISTOL LA
JIN L
KUNCL RW
KANAI Y
HEDIGER MA
WANG YF
SCHIELKE JP
WELTY DF
Citation: Jd. Rothstein et al., KNOCKOUT OF GLUTAMATE TRANSPORTERS REVEALS A MAJOR ROLE FOR ASTROGLIAL TRANSPORT IN EXCITOTOXICITY AND CLEARANCE OF GLUTAMATE, Neuron, 16(3), 1996, pp. 675-686
Citation: Yf. Wang et Df. Welty, THE SIMULTANEOUS ESTIMATION OF THE INFLUX AND EFFLUX BLOOD-BRAIN-BARRIER PERMEABILITIES OF GABAPENTIN USING A MICRODIALYSIS-PHARMACOKINETICAPPROACH, Pharmaceutical research, 13(3), 1996, pp. 398-403
Citation: Df. Welty et al., POTENTIAL TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS WITH GABAPENTIN - A HYPOTHESIS, The Annals of pharmacotherapy, 29(11), 1995, pp. 1164-1167
Authors:
GOLDLUST A
SU TZ
WELTY DF
TAYLOR CP
OXENDER DL
Citation: A. Goldlust et al., EFFECTS OF ANTICONVULSANT DRUG GABAPENTIN ON THE ENZYMES IN METABOLICPATHWAYS OF GLUTAMATE AND GABA, Epilepsy research, 22(1), 1995, pp. 1-11
Authors:
WOLFGANG GHI
ROBERTSON DG
WELTY DF
METZ AL
Citation: Ghi. Wolfgang et al., HEPATIC AND ADRENAL TOXICITY OF A NOVEL LIPID REGULATOR IN BEAGLE DOGS, Fundamental and applied toxicology, 26(2), 1995, pp. 272-281
Authors:
WELTY DF
SCHIELKE GP
VARTANIAN MG
TAYLOR CP
Citation: Df. Welty et al., GABAPENTIN ANTICONVULSANT ACTION IN RATS - DISEQUILIBRIUM WITH PEAK DRUG CONCENTRATIONS IN PLASMA AND BRAIN MICRODIALYSATE, Epilepsy research, 16(3), 1993, pp. 175-181